| Market Cap | €166,498 | |
| Enterprise Value | €30.1M | |
| Revenue | €370.0M | −3.3% |
| Gross Profit | — | — |
| EBITDA | €29.6M | +28.8% |
| Net Income | €4.8M | — |
| Diluted EPS | €680.00 | — |
| Free Cash Flow | €33.8M | +34.1% |
| DPS (FY2023) | — |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20232023-12-31 | — | — | reported |
| FY20222022-12-31 | — | — | reported |
| FY20212021-12-31 | — | — | reported |
| Ratio | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 5y | vs own |
|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||
| Operating Margin | 2.76% | 0.88% | 0.04% | 2.13% | 4.50% | 90% | |
| EBITDA Margin | 8.28% | 5.70% | 4.45% | 6.00% | 8.00% | 70% | |
| NOPAT Margin | 2.63% | 0.00% | 0.03% | 0.00% | 2.63% | 90% | |
| Net Margin | 3.27% | −0.53% | −3.14% | −0.86% | 1.30% | 70% | |
| FCF Margin | 6.06% | 3.93% | −0.57% | 6.58% | 9.13% | 90% | |
| FCFF Margin | 6.65% | 3.93% | — | 6.58% | 10.18% | 88% | |
| FCFE Margin | 5.27% | 14.04% | 1.30% | 2.76% | 4.09% | 50% | |
| OCF Margin | 6.51% | 4.25% | 0.03% | 7.17% | 10.16% | 90% | |
| Capex Intensity | 0.45% | 0.32% | 0.61% | 0.59% | 1.03% | 90% | |
| ▸Returns on Capital · 6 ratios | |||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||
| ▸Earnings quality · 7 ratios | |||||||
| ▸Liquidity & coverage · 8 ratios | |||||||
| ▸Leverage · 9 ratios | |||||||
| ▸Working capital · 3 ratios | |||||||
| ▸Capital allocation · 5 ratios | |||||||
The five drivers multiply to 19.6% vs reported ROE 26.2%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | €258.5M | €328.8M | €371.0M | €382.8M | €370.0M |
| YoY % | +27.2% | +12.8% | +3.2% | -3.3% | |
| Operating Income | €7.1M | €2.9M | €153,000 | €8.2M | €16.7M |
| YoY % | -59.4% | -94.7% | +5234.6% | +104.2% | |
| Interest Expense | €1.6M | €3.3M | €15.0M | €8.3M | €6.6M |
| YoY % | +104.5% | +356.1% | -44.9% | -19.7% | |
| Interest & Investment Income | €5.5M | €790,000 | €4.9M | €4.5M | €3.6M |
| YoY % | -85.6% | +520.5% | -8.1% | -19.5% | |
| Equity Method Income | — | €87,000 | €85,000 | €3,000 | €32,000 |
| YoY % | -2.3% | -96.5% | +966.7% | ||
| Pretax Income | €11.3M | €937,000 | -€11.2M | €4.6M | €12.1M |
| YoY % | -91.7% | +160.6% | |||
| Income Tax | €507,000 | €1.4M | -€818,000 | €5.1M | €5.0M |
| YoY % | +175.0% | -1.6% | |||
| Net Income (incl. NCI) | €10.8M | -€457,000 | -€10.4M | -€460,000 | €7.1M |
| Minority Interest (P&L) | €2.3M | €1.3M | €1.3M | €2.8M | €2.3M |
| YoY % | -44.5% | -1.7% | +123.3% | -20.5% | |
| Net Income | €8.4M | -€1.8M | -€11.6M | -€3.3M | €4.8M |
| EPS (Basic) | €1230.00 | -€250.00 | -€1690.00 | -€480.00 | €680.00 |
| EPS (Diluted) | €1230.00 | -€250.00 | -€1690.00 | -€480.00 | €680.00 |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
